Reynolds Cameron John 4
4 · VOLITIONRX LTD · Filed Dec 6, 2019
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
Reynolds Cameron John
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2019-12-05$4.24/sh+1,100$4,664→ 1,122,273 total
Holdings
- 1,007,718(indirect: Concord International, Inc.)
Common Stock
- 34,076(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The shares of Common Stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of Common Stock held by Concord International, Inc.